Cargando…
Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival
OBJECTIVE: Acute myocardial infarction (AMI) carries increased risk of mortality and excess costs. Disease Management Programs (DMPs) providing guideline-recommended care for chronic diseases seem an intuitively appealing way to enhance health outcomes for patients with chronic conditions such as AM...
Autores principales: | Kirsch, Florian, Becker, Christian, Schramm, Anja, Maier, Werner, Leidl, Reiner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214389/ https://www.ncbi.nlm.nih.gov/pubmed/32006188 http://dx.doi.org/10.1007/s10198-020-01158-z |
Ejemplares similares
-
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
por: Kirsch, Florian, et al.
Publicado: (2020) -
Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life
por: Huber, Manuel B., et al.
Publicado: (2021) -
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction
por: Arnold, Suzanne V., et al.
Publicado: (2020) -
Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study
por: Kirsch, Florian, et al.
Publicado: (2019) -
Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
por: Jortveit, Jarle, et al.
Publicado: (2022)